Ryan Nash

Stock Analyst at Goldman Sachs

(3.73)
# 722
Out of 5,132 analysts
169
Total ratings
61.62%
Success rate
4.56%
Average return

Stocks Rated by Ryan Nash

BankUnited
Jan 23, 2026
Maintains: Sell
Price Target: $43$49
Current: $48.73
Upside: +0.55%
Rocket Companies
Oct 29, 2025
Maintains: Neutral
Price Target: $16$22
Current: $18.68
Upside: +17.77%
loanDepot
Oct 29, 2025
Maintains: Sell
Price Target: $1.45$3
Current: $2.03
Upside: +47.78%
Bread Financial Holdings
Oct 24, 2025
Maintains: Sell
Price Target: $60$68
Current: $72.37
Upside: -6.04%
First Citizens BancShares
Oct 6, 2025
Maintains: Buy
Price Target: $2,250$1,950
Current: $2,005.87
Upside: -2.79%
Regions Financial
Apr 22, 2025
Maintains: Buy
Price Target: $28$25
Current: $29.74
Upside: -15.94%
M&T Bank
Nov 26, 2024
Maintains: Neutral
Price Target: $216$243
Current: $228.71
Upside: +6.25%
KeyCorp
Nov 26, 2024
Maintains: Buy
Price Target: $20$23
Current: $21.70
Upside: +5.99%
Huntington Bancshares
Nov 26, 2024
Maintains: Buy
Price Target: $16$20
Current: $17.26
Upside: +15.87%
Finance of America Companies
May 12, 2022
Maintains: Neutral
Price Target: $39$25
Current: $21.76
Upside: +14.89%
Maintains: Neutral
Price Target: $6$5.25
Current: $4.89
Upside: +7.36%
Maintains: Buy
Price Target: $45$50
Current: $40.80
Upside: +22.55%
Maintains: Buy
Price Target: $367$330
Current: $337.50
Upside: -2.22%
Maintains: Sell
Price Target: $26$29
Current: $26.31
Upside: +10.22%
Maintains: Neutral
Price Target: $59$67
Current: $61.26
Upside: +9.37%
Maintains: Buy
Price Target: $50$60
Current: $51.90
Upside: +15.61%
Maintains: Neutral
Price Target: $19$23
Current: $24.56
Upside: -6.35%
Maintains: Buy
Price Target: $182$205
Current: $207.37
Upside: -1.14%
Maintains: Neutral
Price Target: $68$60
Current: $61.42
Upside: -2.31%
Maintains: Buy
Price Target: $32$36
Current: $52.86
Upside: -31.90%
Maintains: Neutral
Price Target: $26$29
Current: $43.29
Upside: -33.01%
Maintains: Buy
Price Target: $35$40
Current: $71.38
Upside: -43.96%
Maintains: Buy
Price Target: $47$41
Current: $65.10
Upside: -37.02%